Experimental Hepatitis C Drug Shows Promise in Study
December 18, 2009
Boston (DbTechNo) - Results of a new clinical trial are positive for an experimental drug to treat hepatitis C.
The drug, called ANA598 is in its experimental phase and is manufactured by Anadys Pharmaceuticals.
The study pitted patients given the drug against those given a placebo, with the results proving without a doubt that the drug works.
After only 4 weeks of treatment, 56% of patients with hepatitis C who received the drug showed no signs of the virus in their blood, compared to 20% of the group on placebo treatment.
The only main side effect associated with the drug was a rash.
News of the positive drug study has done wonders for the company’s shares sending them up by 9 percent.
Comments
One Response to “Experimental Hepatitis C Drug Shows Promise in Study”
All comments are moderated.
If your comment is approved, it will be posted within 24 hours
Breaking News
Shawn Thornton Batters Matt Cooke SenselessIt was only a matter of time before the Boston Bruins played the Pittsburgh Penguins, allowing for a little payback to be...
Fess Parker, AKA Davy Crockett Dies at 85Boston (DbTechNo) - It is being reported that Fess Parker, star of Davy Crockett has died at the age of 85. According to...
Joslyn James Releases Racy Texts Sent to Her by Tiger WoodsBoston (DbTechNo) - Just when Tiger Woods appears to be getting his life back on track, another mistress comes crawling...
Can this medicin is used for liver cancer…….Plesae revert back with answer..
Thanks!!!
Rama